Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
SMALL CAP BASIC
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cytrx | CYTR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.31 | 0.00 | 0.00 | 0.00 | 0.31 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.30 | 0.3001 | 0.00 | 0.00% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
Cytrx Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 10.43M | 33.64M | $ -12.71M | -0.42 | -0.82 | 32.26M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 294.31k | $ - | 0.00% | - | - |
Cytrx News
PROMOTEDGSRX Industries Inc. to Report Record Revenues for 2nd Quarter 2019 IHNW • Tue Jul 16, 2019 7:00 AM (7 hours ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Wed Jun 26, 2019 9:01 AM (3 weeks ago)
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) • Wed Jun 26, 2019 6:16 AM (3 weeks ago)
Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... Edgar (US Regulatory) • Mon Jun 24, 2019 9:38 AM (3 weeks ago)
Statement of Ownership (sc 13g) Edgar (US Regulatory) • Thu Jun 06, 2019 4:35 PM (1 month ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Fri May 31, 2019 9:01 AM (2 months ago)
CytRx Corporation to Commence Trading on OTCQB Venture Market PR Newswire (US) • Fri May 31, 2019 9:00 AM (2 months ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0 | 0 | 0 | 0.0000 | 0 | - | - |
| 1 Month | 0 | 0 | 0 | 0.0000 | 0 | - | - |
| 3 Months | 0.56 | 0.72 | 0.3 | 0.4677 | 250k | -0.25 | -44.64% |
| 6 Months | 0.605 | 0.7789 | 0.3 | 0.5787 | 178k | -0.295 | -48.76% |
| 1 Year | 1.26 | 1.27 | 0.3 | 0.6848 | 155k | -0.95 | -75.40% |
| 3 Years | 3.8316 | 5.988 | 0.3 | 3.5464 | 2M | -3.5216 | -91.91% |
| 5 Years | 21 | 32.52 | 0.3 | 7.3662 | 1M | -20.69 | -98.52% |
Cytrx Description
| CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS). |
